Review





Similar Products

94
Bioss anti crt
TSP-1 promotes the translocation of CRT to the cell surface in MC-3 cells. Cells were stained with an <t>APC-conjugated</t> <t>anti-CRT</t> antibody, and CRT expression on the cell membrane is presented as mean fluorescence intensity. At the 72 h point: **P<0.01 vs. the control group; # P<0.05 vs. the TSP-1 group; and ▲ P<0.05 vs. the TSP-1 + ISRIB group. MFI, mean fluorescence intensity; CRT, calreticulin; TSP-1, thrombospondin-1.
Anti Crt, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crt/pmc13107154-63-21-26?v=Bioss
Average 94 stars, based on 1 article reviews
anti crt - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

86
Varian Medical replanning ct ct1
TSP-1 promotes the translocation of CRT to the cell surface in MC-3 cells. Cells were stained with an <t>APC-conjugated</t> <t>anti-CRT</t> antibody, and CRT expression on the cell membrane is presented as mean fluorescence intensity. At the 72 h point: **P<0.01 vs. the control group; # P<0.05 vs. the TSP-1 group; and ▲ P<0.05 vs. the TSP-1 + ISRIB group. MFI, mean fluorescence intensity; CRT, calreticulin; TSP-1, thrombospondin-1.
Replanning Ct Ct1, supplied by Varian Medical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crt/pm42241770-81-26-28?v=Varian+Medical
Average 86 stars, based on 1 article reviews
replanning ct ct1 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Boston Scientific Corporation madit crt
Estimated ICERs and 95% CIs for <t>the</t> <t>MADIT-CRT</t> and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).
Madit Crt, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crt/pmc13164937-355-10-16?v=Boston+Scientific+Corporation
Average 86 stars, based on 1 article reviews
madit crt - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Boston Scientific Corporation madit crt data
Estimated ICERs and 95% CIs for <t>the</t> <t>MADIT-CRT</t> and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).
Madit Crt Data, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crt/pm42118799-349-12-3?v=Boston+Scientific+Corporation
Average 86 stars, based on 1 article reviews
madit crt data - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Affinity Biosciences anti crt
Estimated ICERs and 95% CIs for <t>the</t> <t>MADIT-CRT</t> and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).
Anti Crt, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crt/pmc13163726-55-19-23?v=Affinity+Biosciences
Average 86 stars, based on 1 article reviews
anti crt - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Biostar Inc crt d implantation
Estimated ICERs and 95% CIs for <t>the</t> <t>MADIT-CRT</t> and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).
Crt D Implantation, supplied by Biostar Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crt/pmc13252480-193-21-4?v=Biostar+Inc
Average 86 stars, based on 1 article reviews
crt d implantation - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Wuhan Sanying Biotechnology crt
Estimated ICERs and 95% CIs for <t>the</t> <t>MADIT-CRT</t> and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).
Crt, supplied by Wuhan Sanying Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crt/10__1016_slash_j__matdes__2026__116193-48-154-166?v=Wuhan+Sanying+Biotechnology
Average 86 stars, based on 1 article reviews
crt - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Abbott Laboratories single coil icd crt d devices
Estimated ICERs and 95% CIs for <t>the</t> <t>MADIT-CRT</t> and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).
Single Coil Icd Crt D Devices, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crt/pm42055103-23-5-12?v=Abbott+Laboratories
Average 86 stars, based on 1 article reviews
single coil icd crt d devices - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Abbott Laboratories crt d devices
Estimated ICERs and 95% CIs for <t>the</t> <t>MADIT-CRT</t> and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).
Crt D Devices, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crt/pm42055103-35-8-15?v=Abbott+Laboratories
Average 86 stars, based on 1 article reviews
crt d devices - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

Image Search Results


TSP-1 promotes the translocation of CRT to the cell surface in MC-3 cells. Cells were stained with an APC-conjugated anti-CRT antibody, and CRT expression on the cell membrane is presented as mean fluorescence intensity. At the 72 h point: **P<0.01 vs. the control group; # P<0.05 vs. the TSP-1 group; and ▲ P<0.05 vs. the TSP-1 + ISRIB group. MFI, mean fluorescence intensity; CRT, calreticulin; TSP-1, thrombospondin-1.

Journal: Oncology Letters

Article Title: Thrombospondin-1 triggers calreticulin expression in human mucoepidermoid carcinoma MC-3 cells via the PERK/CHOP pathway

doi: 10.3892/ol.2026.15589

Figure Lengend Snippet: TSP-1 promotes the translocation of CRT to the cell surface in MC-3 cells. Cells were stained with an APC-conjugated anti-CRT antibody, and CRT expression on the cell membrane is presented as mean fluorescence intensity. At the 72 h point: **P<0.01 vs. the control group; # P<0.05 vs. the TSP-1 group; and ▲ P<0.05 vs. the TSP-1 + ISRIB group. MFI, mean fluorescence intensity; CRT, calreticulin; TSP-1, thrombospondin-1.

Article Snippet: Primary antibodies, including anti-PERK (1:1,000; cat. no. MA8131; Abmart Pharmaceutical Technology Co., Ltd.), anti-CHOP (1:1,000; cat. no. WL00880; Wanleibio Co., Ltd.), anti-CRT (1:800; cat. no. bs-5913R; BIOSS) and anti-β-actin (1:5,000; cat. no. 66009-1-Ig; Proteintech Group Inc.), were diluted in 5% BSA and incubated with the membranes overnight at 4°C.

Techniques: Translocation Assay, Staining, Expressing, Membrane, Fluorescence, Control

TSP-1 effects on cell surface CRT expression at 4 h. Cells were stained with an APC-conjugated anti-CRT antibody, and CRT expression on the cell membrane is presented as mean fluorescence intensity. At the 4 h time point. *P<0.05 compared with control group; # P<0.05 compared with TSP-1 action group; and ▲ P<0.05 compared with TSP-1 + ISRIB group. TSP-1, thrombospondin-1; CRT, calreticulin.

Journal: Oncology Letters

Article Title: Thrombospondin-1 triggers calreticulin expression in human mucoepidermoid carcinoma MC-3 cells via the PERK/CHOP pathway

doi: 10.3892/ol.2026.15589

Figure Lengend Snippet: TSP-1 effects on cell surface CRT expression at 4 h. Cells were stained with an APC-conjugated anti-CRT antibody, and CRT expression on the cell membrane is presented as mean fluorescence intensity. At the 4 h time point. *P<0.05 compared with control group; # P<0.05 compared with TSP-1 action group; and ▲ P<0.05 compared with TSP-1 + ISRIB group. TSP-1, thrombospondin-1; CRT, calreticulin.

Article Snippet: Primary antibodies, including anti-PERK (1:1,000; cat. no. MA8131; Abmart Pharmaceutical Technology Co., Ltd.), anti-CHOP (1:1,000; cat. no. WL00880; Wanleibio Co., Ltd.), anti-CRT (1:800; cat. no. bs-5913R; BIOSS) and anti-β-actin (1:5,000; cat. no. 66009-1-Ig; Proteintech Group Inc.), were diluted in 5% BSA and incubated with the membranes overnight at 4°C.

Techniques: Expressing, Staining, Membrane, Fluorescence, Control

Estimated ICERs and 95% CIs for the MADIT-CRT and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).

Journal: Biometrics

Article Title: Regression methods for cost-effectiveness analysis with different censoring times or terminating events for survival time and costs

doi: 10.1093/biomtc/ujag073

Figure Lengend Snippet: Estimated ICERs and 95% CIs for the MADIT-CRT and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).

Article Snippet: While the data transfer and use agreements prohibit making the MADIT-CRT and MADIT-II datasets publicly available, Boston Scientific may share the data with qualified researchers, available at https://www.bostonscientific.com/en-US/data-sharing-requests.html

Techniques: